Global Gefitinib Market

Market Size in USD Billion

CAGR : 17.60%

USD 1.14

2025

USD 4.17

2033

Forecast Period	2025 - 2033
Market Size (Base Year)	USD 1.14 Billion
Market Size (Forecast)	USD 4.17 Billion
CAGR	17.60%
Major Market Players	Data provided in full report

The Global Gefitinib Market study further sheds light on the sector by revealing the relevant market drivers and restraints that effect the growth during the forecast period. Furthermore, the study encompasses various analytical discussions that our analyst will put forth after observing the market with our in-house methodology which is further verified by primary and secondary research means.

Data provided by Extent Research. Source: https://www.extentresearch.com/gefitinib-market

Some of the key players operating in the global Gefitinib market include AstraZeneca, Qilu Pharmaceutical, Natco Pharma, Celon Laboratories, Hetero Drugs, Dr Reddy’s Laboratories, Zuventus Healthcare, United Biotech, Panacea Biotec, Cipla, Glenmark Pharmaceuticals, Nobel Ilac Sanayii Ve Ticaret, Accure Labs, Cadila Pharmaceuticals, Ethypharm, Flagship Biotech International, Globela Pharma, Jodas Expoim, Nishchay Pharmaceuticals, Sichuan Xieli Pharmaceutical, . Our researchers aim to highlight to the clients most profitable opportunities for growth and hence aim to assist them by changing our perspective for every market study we craft. In addition, the section covers the set of manufacturers, vendors, and consumer base w.r.t to the key players in order to grasp our reader the current set of challenges faced by the market during the entire period of the forecast. The research report offers a wider aspect on the COVID-19 impact analysis that has downgraded world markets on a variety of business sectors. The market focuses on a study that is thoroughly based on the valuation and analytical cornerstones for the Gefitinib Market.

Segmentation of the Global Gefitinib Market:

Product type

10 Tables/Box, 30 Tables/Box, 90 Tables/Box,

by Application

Hospital, Clinic, Drug Center, Other,

The basic segmentation of the Gefitinib market reported in the study includes:

Key Market Trends
Growth Forecast
Market Share
Production and Sales Figures
Manufacturers Compliance
Technological Advancements

Along with the market growth points, the study also targets the risks associated with the Gefitinib industry in a detailed manner. The report mainly focuses on market categories that are bound to distribute the Gefitinib industry in an analytical manner that will further help you in grasping a better overview of the market. The competitive landscape of the market study includes a wider analysis on the regions including by Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa which are expected to capture the essence of the market in its widest category.

Report Scope and Market Segmentation

ATTRIBUTES	Global Gefitinib Market KEY MARKET INSIGHTS
Segments Covered	By Product Type: All Products Type Includes By Application: All Application Type Includes By End User: All End User Type Includes By Distribution Channel: All Distribution Channel Includes
Countries Covered	North America U.S., Canada, Mexico Europe Germany, United Kingdom, France, Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe Asia-Pacific China, India, Japan, New Zealand, South Korea, Australia, Southeast Asia, Rest of Asia Pacific Latin America Brazil, Argentina, Rest of Latin America Middle East & Africa Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa
Key Market Players	Leading Tier 1 Corporations Prominent Regional Manufacturers Emerging Market Disruptors Technology Integrators & Suppliers *Complete vendor layout of 15+ major players provided in the final report.
Market Opportunities	Market Size and Growth: Quantifying the total addressable market (TAM) and projected growth rates to assess financial viability. Customer Segmentation: Identifying target audience behaviors, pain points, and specific unfulfilled demands. Competitive Landscape: Analyzing existing competitors' strengths, weaknesses, and market share to pinpoint gaps and opportunities. Industry Trends: Mapping technological, regulatory, and economic shifts that create favorable conditions for market entry. Risk Assessment: Evaluating barriers to entry and operational challenges alongside strategic roadmaps for mitigation.
Value Added Data Infosets	In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by our expert team also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.

Meet the Team

Julie

Author

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly...

Priya M

Reviewed By

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives...

Learn more about Priya M

BASIC ATTRIBUTES \| KEY MARKET INSIGHTS
Report Title	Global Gefitinib Market
Base Year	2025
Forecast Period	2025 - 2033
Market Size (Base)	USD 1.14 Billion
Projected Size	USD 4.17 Billion
CAGR	17.60%

                            1 Study Coverage
    1.1 Gefitinib Product Introduction
    1.2 Market by Type
        1.2.1 Global Gefitinib Market Size Growth Rate by Type, 2017 VS 2021 VS 2035
        1.2.2 10 Tables/Box
        1.2.3 30 Tables/Box
        1.2.4 90 Tables/Box
    1.3 Market by Application
        1.3.1 Global Gefitinib Market Size Growth Rate by Application, 2017 VS 2021 VS 2035
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Drug Center
        1.3.5 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Gefitinib Sales Estimates and Forecasts 2017-2035
    2.2 Global Gefitinib Revenue Estimates and Forecasts 2017-2035
    2.3 Global Gefitinib Revenue by Region: 2017 VS 2021 VS 2035
    2.4 Global Gefitinib Sales by Region
        2.4.1 Global Gefitinib Sales by Region (2017-2022)
        2.4.2 Global Sales Gefitinib by Region (2023-2035)
    2.5 Global Gefitinib Revenue by Region
        2.5.1 Global Gefitinib Revenue by Region (2017-2022)
        2.5.2 Global Gefitinib Revenue by Region (2023-2035)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Gefitinib Sales by Manufacturers
        3.1.1 Global Top Gefitinib Manufacturers by Sales (2017-2022)
        3.1.2 Global Gefitinib Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Gefitinib in 2021
    3.2 Global Gefitinib Revenue by Manufacturers
        3.2.1 Global Gefitinib Revenue by Manufacturers (2017-2022)
        3.2.2 Global Gefitinib Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Gefitinib Revenue in 2021
    3.3 Global Gefitinib Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Gefitinib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Gefitinib Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Gefitinib Sales by Type
        4.1.1 Global Gefitinib Historical Sales by Type (2017-2022)
        4.1.2 Global Gefitinib Forecasted Sales by Type (2023-2035)
        4.1.3 Global Gefitinib Sales Market Share by Type (2017-2035)
    4.2 Global Gefitinib Revenue by Type
        4.2.1 Global Gefitinib Historical Revenue by Type (2017-2022)
        4.2.2 Global Gefitinib Forecasted Revenue by Type (2023-2035)
        4.2.3 Global Gefitinib Revenue Market Share by Type (2017-2035)
    4.3 Global Gefitinib Price by Type
        4.3.1 Global Gefitinib Price by Type (2017-2022)
        4.3.2 Global Gefitinib Price Forecast by Type (2023-2035)
5 Market Size by Application
    5.1 Global Gefitinib Sales by Application
        5.1.1 Global Gefitinib Historical Sales by Application (2017-2022)
        5.1.2 Global Gefitinib Forecasted Sales by Application (2023-2035)
        5.1.3 Global Gefitinib Sales Market Share by Application (2017-2035)
    5.2 Global Gefitinib Revenue by Application
        5.2.1 Global Gefitinib Historical Revenue by Application (2017-2022)
        5.2.2 Global Gefitinib Forecasted Revenue by Application (2023-2035)
        5.2.3 Global Gefitinib Revenue Market Share by Application (2017-2035)
    5.3 Global Gefitinib Price by Application
        5.3.1 Global Gefitinib Price by Application (2017-2022)
        5.3.2 Global Gefitinib Price Forecast by Application (2023-2035)
6 North America
    6.1 North America Gefitinib Market Size by Type
        6.1.1 North America Gefitinib Sales by Type (2017-2035)
        6.1.2 North America Gefitinib Revenue by Type (2017-2035)
    6.2 North America Gefitinib Market Size by Application
        6.2.1 North America Gefitinib Sales by Application (2017-2035)
        6.2.2 North America Gefitinib Revenue by Application (2017-2035)
    6.3 North America Gefitinib Market Size by Country
        6.3.1 North America Gefitinib Sales by Country (2017-2035)
        6.3.2 North America Gefitinib Revenue by Country (2017-2035)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Gefitinib Market Size by Type
        7.1.1 Europe Gefitinib Sales by Type (2017-2035)
        7.1.2 Europe Gefitinib Revenue by Type (2017-2035)
    7.2 Europe Gefitinib Market Size by Application
        7.2.1 Europe Gefitinib Sales by Application (2017-2035)
        7.2.2 Europe Gefitinib Revenue by Application (2017-2035)
    7.3 Europe Gefitinib Market Size by Country
        7.3.1 Europe Gefitinib Sales by Country (2017-2035)
        7.3.2 Europe Gefitinib Revenue by Country (2017-2035)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Gefitinib Market Size by Type
        8.1.1 Asia Pacific Gefitinib Sales by Type (2017-2035)
        8.1.2 Asia Pacific Gefitinib Revenue by Type (2017-2035)
    8.2 Asia Pacific Gefitinib Market Size by Application
        8.2.1 Asia Pacific Gefitinib Sales by Application (2017-2035)
        8.2.2 Asia Pacific Gefitinib Revenue by Application (2017-2035)
    8.3 Asia Pacific Gefitinib Market Size by Region
        8.3.1 Asia Pacific Gefitinib Sales by Region (2017-2035)
        8.3.2 Asia Pacific Gefitinib Revenue by Region (2017-2035)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Gefitinib Market Size by Type
        9.1.1 Latin America Gefitinib Sales by Type (2017-2035)
        9.1.2 Latin America Gefitinib Revenue by Type (2017-2035)
    9.2 Latin America Gefitinib Market Size by Application
        9.2.1 Latin America Gefitinib Sales by Application (2017-2035)
        9.2.2 Latin America Gefitinib Revenue by Application (2017-2035)
    9.3 Latin America Gefitinib Market Size by Country
        9.3.1 Latin America Gefitinib Sales by Country (2017-2035)
        9.3.2 Latin America Gefitinib Revenue by Country (2017-2035)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Gefitinib Market Size by Type
        10.1.1 Middle East and Africa Gefitinib Sales by Type (2017-2035)
        10.1.2 Middle East and Africa Gefitinib Revenue by Type (2017-2035)
    10.2 Middle East and Africa Gefitinib Market Size by Application
        10.2.1 Middle East and Africa Gefitinib Sales by Application (2017-2035)
        10.2.2 Middle East and Africa Gefitinib Revenue by Application (2017-2035)
    10.3 Middle East and Africa Gefitinib Market Size by Country
        10.3.1 Middle East and Africa Gefitinib Sales by Country (2017-2035)
        10.3.2 Middle East and Africa Gefitinib Revenue by Country (2017-2035)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 AstraZeneca
        11.1.1 AstraZeneca Corporation Information
        11.1.2 AstraZeneca Overview
        11.1.3 AstraZeneca Gefitinib Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 AstraZeneca Gefitinib Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 AstraZeneca Recent Developments
    11.2 Qilu Pharmaceutical
        11.2.1 Qilu Pharmaceutical Corporation Information
        11.2.2 Qilu Pharmaceutical Overview
        11.2.3 Qilu Pharmaceutical Gefitinib Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Qilu Pharmaceutical Gefitinib Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Qilu Pharmaceutical Recent Developments
    11.3 Natco Pharma
        11.3.1 Natco Pharma Corporation Information
        11.3.2 Natco Pharma Overview
        11.3.3 Natco Pharma Gefitinib Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Natco Pharma Gefitinib Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Natco Pharma Recent Developments
    11.4 Celon Laboratories
        11.4.1 Celon Laboratories Corporation Information
        11.4.2 Celon Laboratories Overview
        11.4.3 Celon Laboratories Gefitinib Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Celon Laboratories Gefitinib Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Celon Laboratories Recent Developments
    11.5 Hetero Drugs
        11.5.1 Hetero Drugs Corporation Information
        11.5.2 Hetero Drugs Overview
        11.5.3 Hetero Drugs Gefitinib Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Hetero Drugs Gefitinib Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Hetero Drugs Recent Developments
    11.6 Dr Reddy's Laboratories
        11.6.1 Dr Reddy's Laboratories Corporation Information
        11.6.2 Dr Reddy's Laboratories Overview
        11.6.3 Dr Reddy's Laboratories Gefitinib Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Dr Reddy's Laboratories Gefitinib Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Dr Reddy's Laboratories Recent Developments
    11.7 Zuventus Healthcare
        11.7.1 Zuventus Healthcare Corporation Information
        11.7.2 Zuventus Healthcare Overview
        11.7.3 Zuventus Healthcare Gefitinib Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Zuventus Healthcare Gefitinib Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Zuventus Healthcare Recent Developments
    11.8 United Biotech
        11.8.1 United Biotech Corporation Information
        11.8.2 United Biotech Overview
        11.8.3 United Biotech Gefitinib Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 United Biotech Gefitinib Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 United Biotech Recent Developments
    11.9 Panacea Biotec
        11.9.1 Panacea Biotec Corporation Information
        11.9.2 Panacea Biotec Overview
        11.9.3 Panacea Biotec Gefitinib Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Panacea Biotec Gefitinib Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Panacea Biotec Recent Developments
    11.10 Cipla
        11.10.1 Cipla Corporation Information
        11.10.2 Cipla Overview
        11.10.3 Cipla Gefitinib Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Cipla Gefitinib Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Cipla Recent Developments
    11.11 Glenmark Pharmaceuticals
        11.11.1 Glenmark Pharmaceuticals Corporation Information
        11.11.2 Glenmark Pharmaceuticals Overview
        11.11.3 Glenmark Pharmaceuticals Gefitinib Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Glenmark Pharmaceuticals Gefitinib Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Glenmark Pharmaceuticals Recent Developments
    11.12 Nobel Ilac Sanayii Ve Ticaret
        11.12.1 Nobel Ilac Sanayii Ve Ticaret Corporation Information
        11.12.2 Nobel Ilac Sanayii Ve Ticaret Overview
        11.12.3 Nobel Ilac Sanayii Ve Ticaret Gefitinib Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Nobel Ilac Sanayii Ve Ticaret Gefitinib Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Nobel Ilac Sanayii Ve Ticaret Recent Developments
    11.13 Accure Labs
        11.13.1 Accure Labs Corporation Information
        11.13.2 Accure Labs Overview
        11.13.3 Accure Labs Gefitinib Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Accure Labs Gefitinib Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Accure Labs Recent Developments
    11.14 Cadila Pharmaceuticals
        11.14.1 Cadila Pharmaceuticals Corporation Information
        11.14.2 Cadila Pharmaceuticals Overview
        11.14.3 Cadila Pharmaceuticals Gefitinib Sales, Price, Revenue and Gross Margin (2017-2022)
        11.14.4 Cadila Pharmaceuticals Gefitinib Product Model Numbers, Pictures, Descriptions and Specifications
        11.14.5 Cadila Pharmaceuticals Recent Developments
    11.15 Ethypharm
        11.15.1 Ethypharm Corporation Information
        11.15.2 Ethypharm Overview
        11.15.3 Ethypharm Gefitinib Sales, Price, Revenue and Gross Margin (2017-2022)
        11.15.4 Ethypharm Gefitinib Product Model Numbers, Pictures, Descriptions and Specifications
        11.15.5 Ethypharm Recent Developments
    11.16 Flagship Biotech International
        11.16.1 Flagship Biotech International Corporation Information
        11.16.2 Flagship Biotech International Overview
        11.16.3 Flagship Biotech International Gefitinib Sales, Price, Revenue and Gross Margin (2017-2022)
        11.16.4 Flagship Biotech International Gefitinib Product Model Numbers, Pictures, Descriptions and Specifications
        11.16.5 Flagship Biotech International Recent Developments
    11.17 Globela Pharma
        11.17.1 Globela Pharma Corporation Information
        11.17.2 Globela Pharma Overview
        11.17.3 Globela Pharma Gefitinib Sales, Price, Revenue and Gross Margin (2017-2022)
        11.17.4 Globela Pharma Gefitinib Product Model Numbers, Pictures, Descriptions and Specifications
        11.17.5 Globela Pharma Recent Developments
    11.18 Jodas Expoim
        11.18.1 Jodas Expoim Corporation Information
        11.18.2 Jodas Expoim Overview
        11.18.3 Jodas Expoim Gefitinib Sales, Price, Revenue and Gross Margin (2017-2022)
        11.18.4 Jodas Expoim Gefitinib Product Model Numbers, Pictures, Descriptions and Specifications
        11.18.5 Jodas Expoim Recent Developments
    11.19 Nishchay Pharmaceuticals
        11.19.1 Nishchay Pharmaceuticals Corporation Information
        11.19.2 Nishchay Pharmaceuticals Overview
        11.19.3 Nishchay Pharmaceuticals Gefitinib Sales, Price, Revenue and Gross Margin (2017-2022)
        11.19.4 Nishchay Pharmaceuticals Gefitinib Product Model Numbers, Pictures, Descriptions and Specifications
        11.19.5 Nishchay Pharmaceuticals Recent Developments
    11.20 Sichuan Xieli Pharmaceutical
        11.20.1 Sichuan Xieli Pharmaceutical Corporation Information
        11.20.2 Sichuan Xieli Pharmaceutical Overview
        11.20.3 Sichuan Xieli Pharmaceutical Gefitinib Sales, Price, Revenue and Gross Margin (2017-2022)
        11.20.4 Sichuan Xieli Pharmaceutical Gefitinib Product Model Numbers, Pictures, Descriptions and Specifications
        11.20.5 Sichuan Xieli Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Gefitinib Industry Chain Analysis
    12.2 Gefitinib Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Gefitinib Production Mode & Process
    12.4 Gefitinib Sales and Marketing
        12.4.1 Gefitinib Sales Channels
        12.4.2 Gefitinib Distributors
    12.5 Gefitinib Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Gefitinib Industry Trends
    13.2 Gefitinib Market Drivers
    13.3 Gefitinib Market Challenges
    13.4 Gefitinib Market Restraints
14 Key Findings in The Global Gefitinib Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer                        

Research Methodology

Data collection and base year analysis are done using proprietary data collection modules with large sample sizes. The process includes obtaining market information through extensive secondary sources, paid databases, and verifying data via primary (industry expert) validation.

Our market models include Vendor Positioning Grids, Market Timeline Analysis, Company Market Share Analysis, and Top-Down/Bottom-Up forecasting models. To know more about the research methodology, drop an inquiry to speak to our industry experts.

Speak to Analyst

Global Gefitinib Market